New Key Statistics Module, Z-Score and F-Score
OTCPK:GENPF Key Ratios
Market Cap $ M | 1.53 |
Enterprise Value $ M | 2.06 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.05 |
Beneish M-Score | -16.73 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -97.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.72 |
EV-to-EBITDA | -0.75 |
PEG | -- |
Shares Outstanding M | 59.22 |
Net Margin (%) | -99,925.00 |
Operating Margin % | -10,325.00 |
Pre-tax Margin (%) | -99,925.00 |
Quick Ratio | 0.04 |
Current Ratio | 0.14 |
ROA % (ttm) | -417.05 |
ROE % (ttm) | -- |
ROIC % (ttm) | -21.94 |
Dividend Yield % | -- |
Altman Z-Score | -135.57 |
GENPF Number of Guru Trades
GENPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:GENPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GENPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Genix Pharmaceuticals Corp Insider Transactions
No Available Data
News about OTCPK:GENPF
Total 0- 1